Linkage of laboratory results to medicare fee-for-service claims

Medical Care

Volumn 53, Issue 11, 2015, Pages 974-979

  Hammill, Bradley G ^a   Curtis, Lesley H ^a,b   Qualls, Laura G ^a   Hastings, Susan N ^b,c,d,e,f   Wang, Virginia ^b,d   Maciejewski, Matthew L ^b,d  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b Department of Medicine ^*  (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Center for Health Services Research in Primary Care   (United States)

^e Post Doctoral Training Veteran Integrated Service Network 19 Mental Illness Research   (United States)

^f DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Clinical laboratory services; Medical record linkage; Medicare

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AGED; ARTICLE; COMPARATIVE EFFECTIVENESS; DEMOGRAPHY; FEMALE; HEALTH CARE QUALITY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL FEE; MEDICARE; PATIENT SAFETY; PRIORITY JOURNAL; VERY ELDERLY; ECONOMICS; INSURANCE; LABORATORY DIAGNOSIS; REIMBURSEMENT; STANDARDS; STATISTICS AND NUMERICAL DATA; UNITED STATES;

CLINICAL LABORATORY SERVICES; FEE-FOR-SERVICE PLANS; FEMALE; HUMANS; INSURANCE CLAIM REPORTING; MALE; MEDICARE; QUALITY ASSURANCE, HEALTH CARE; REIMBURSEMENT MECHANISMS; UNITED STATES;

EID: 84944313700     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/MLR.0000000000000420     Document Type: Article

References (20)

1. Zhan C, Miller M. Administrative data based patient safety research: a critical review. Qual Saf Health Care. 2003;12:ii58-ii63.
2. Birnbaum HG, Cremieux PY, Greenberg PE, et al. Using healthcare claims data for outcomes research and pharmacoeconomic analyses. Pharmacoeconomics. 1999;16:1-8.
3. Raebel MA, Haynes K, Woodworth TS, et al. Electronic clinical laboratory test results data tables: lessons from Mini-Sentinel. Pharmacoepidemiol Drug Saf. 2014;23:609-618.
4. MedPAC. Payment Basics: Clinical Laboratory Services Payment System. Washington, DC: MedPAC; 2011.
5. MedPAC. Payment Basics: Clinical Laboratory Services Payment System. Washington, DC: MedPAC; 2013.
6. Goulet JL, Erdos J, Kancir S, et al. Measuring performance directly using the veterans health administration electronic medical record: a comparison with external peer review. Med Care. 2007;45:73-79.
7. Jackson GL, Edelman D, Olsen MK, et al. Benefits of participation in diabetes group visits after trial completion. JAMA Intern Med. 2013;173:590-592.
8. Dublin S, Glazer NL, Smith NL, et al. Diabetes mellitus, glycemic control, and risk of atrial fibrillation. J Gen Intern Med. 2010;25:853-858.
9. Buccaneer, Computer Systems and Service Inc. Chronic conditions data warehouse Medicare administrative data user guide. 2015. Available at: https://www.ccwdata.org/cs/groups/public/documents/document/ccw-userguide.pdf. Accessed August 14, 2015.
10. Buccaneer, Computer Systems and Service Inc. Chronic conditions warehouse categories. 2010. Available at: https://www.ccwdata.org/cs/groups/public/documents/document/ccw-condition-categories.pdf. Accessed February 1, 2015.
11. McDonald C, Huff S, Deckard J, et al. Logical Observation Identifiers Names and Codes (LOINCs) users' guide. 2015. Available at: https://loinc.org/downloads/files/LOINCManual.pdf. Accessed August 14, 2015.
12. Austin PC. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat Simul Comput. 2009;38:1228-1234.
13. Kandilov AMG, Pope GC, Kautter J, et al. The national market for Medicare clinical laboratory testing: implications for payment reform. Medicare Medicaid Res Rev. 2012:2. pii: mmrr.002.02.a04. doi: 10.5600/mmrr.002.02.a04.
14. Simon SR, Andrade SE, Ellis JL, et al. Baseline laboratory monitoring of cardiovascular medications in elderly health maintenance organization enrollees. J Am Geriatr Soc. 2005;53:2165-2169.
15. Hammill BG, Curtis LH, Fonarow GC, et al. Incremental value of clinical data beyond claims data in predicting 30-day outcomes after heart failure hospitalization. Circ Cardiovasc Qual Outcomes. 2011;4:60-67.
16. Pine M, Jordan HS, Elixhauser A, et al. Enhancement of claims data to improve risk adjustment of hospital mortality. JAMA. 2007;297:71-76.
17. Pine M, Jones B, Lou Y. Laboratory values improve predictions of hospital mortality. Int J Qual Health Care. 1998;10:491-501.
18. Jones M, McEwan P, Morgan CL, et al. Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population. Heart. 2005;91:472-477.
19. Raebel MA, McClure DL, Simon SR, et al. Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers. Pharmacoepidemiol Drug Saf. 2007;16:55-64.
20. Schneeweiss S, Rassen JA, Glynn RJ, et al. Supplementing claims data with outpatient laboratory test results to improve confounding adjustment in effectiveness studies of lipid-lowering treatments. BMC Med Res Methodol. 2012;12:180.